Fig. 2
From: Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers
Mutation prevalence in our cohort (PABC: Premenopausal Asian Breast Cancers) and comparison with premenopausal, non-Asian breast cancer patients in The Cancer Genome Atlas. Starred genes indicate significant difference from TCGA data (FDR q < 0.05). a Comparison of 21 HER2-positive samples against 58 non-Asian TCGA samples. b Comparison of 27 hormone receptor-positive samples against 81 non-Asian TCGA samples. c Comparison of 15 triple-negative breast cancers against 28 non-Asian TCGA samples
